Loncom Pharma provides Perampanel APIs, which are crucial for the formulation of cutting-edge antiepileptic drugs. Perampanel works by selectively antagonizing AMPA receptors, which play a significant role in the propagation of seizures. With a focus on quality and regulatory compliance, these APIs help in formulating treatments that improve the quality of life for patients with epilepsy by effectively reducing seizure frequency.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
